AMT-562 in Patients With Selected Advanced Solid Tumors

Clinical trial NCT06199908 · UNKNOWN

Trial details

NCT number: NCT06199908
Sponsor: Multitude Therapeutics (Australia) Pty Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-05-20
Primary completion: 2025-12-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.